Songnan P. Zhang - Publications

Efficacy Analysis of Capsule Integrity and TACE Combined with Microwave Ablation versus Microwave Ablation Alone for Primary Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: May 28, 2026

Efficacy and safety of TACE combined with MWA followed by immune checkpoint inhibitors and anti-VEGF/tyrosine kinase inhibitors in hepatocellular carcinoma beyond the up-to-7.

Journal: Frontiers in immunology

Published: May 19, 2026

Nanoparticle radiosensitizers in cancer radiotherapy: bridging preclinical promise and clinical reality.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 10, 2026

Transarterial infusion chemotherapy combined with microwave ablation for inoperable triple-negative breast cancer: a case report.

Journal: Frontiers in oncology

Published: May 07, 2026

Metal Nanoparticles as Sensitizers in Energy-Based Therapies for Lung Cancer: From Mechanistic Insights to Clinical Translation.

Journal: International journal of nanomedicine

Published: January 07, 2026

Efficacy and safety of adjuvant short-course immune checkpoint inhibitors following TACE combined with MWA in patients with BCLC A-B hepatocellular carcinoma: a single-arm, prospective, phase II study protocol.

Journal: BMJ open

Published: December 30, 2025

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Journal: Cancer medicine

Published: November 10, 2025

Ginsenoside Rg3 synergizes with near-infrared photothermal therapy to suppress prostate cancer progression by inhibiting RAS signaling and enhancing ARL11-mediated macrophage reprogramming.

Journal: International immunopharmacology

Published: November 06, 2025

Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 16, 2025

Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors versus lenvatinib plus PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumour burden and portal vein tumour thrombus (CHANCE 2416): study protocol of a multicentre, retrospective, target trial emulation design.

Journal: BMJ open

Published: September 10, 2025

Combined TACE and Microwave Ablation for Recurrent Spiegel-Lobe HCC: A Four-Case Series.

Journal: Journal of hepatocellular carcinoma

Published: August 24, 2025

Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody.

Journal: Cancer letters

Published: December 11, 2024